UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

UNCY is currently covered by 4 analysts with an average price target of $4.29. This is a potential upside of $3.15 (276.32%) from yesterday's end of day stock price of $1.14.

Unicycive Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for UNCY is $5, Lowest price target is $3, average price target is $4.29.

Most recent stock forecast was given by BRUCE JACKSON from BENCHMARK on 14-Apr-2024. First documented stock forecast 08-Aug-2021.

Best performing analysts who are covering UNCY - Unicycive Therapeutics:

Ed Arce Elemer Piros Jason Mccarthy Bruce Jackson

Currently out of the existing stock ratings of UNCY, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

$1.97 (191.26%)

3

17 days ago

0/3 (0%)

$1.86 (163.16%)

Buy

4.5

$3.47 (336.89%)

1 months 1 days ago

0/4 (0%)

$3.09 (219.15%)

Buy

5

$3.97 (385.44%)

5

10 months 2 days ago

0/5 (0%)

$3.72 (290.63%)

Buy

6

$4.97 (482.52%)

3

1 years 1 months 23 days ago

0/2 (0%)

$3.94 (191.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on UNCY (Unicycive Therapeutics) with a proven track record?

ED ARCE

Which analyst has the current lower performing score on UNCY (Unicycive Therapeutics) with a proven track record?

BRUCE JACKSON

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Ed Arce has 0 price targets and 0 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Jason Mccarthy with highest potential upside - $4.97

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Bruce Jackson with lowest potential downside - $1.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?